Quality generics

With more than 30 years of experience in the wider healthcare sector and a vision to provide the most innovative & trustworthy solutions in the market, Rontis is a trusted leader with a reputation for exceptional quality. Our core business lies in developing, producing and distributing high-quality and specialty medicines following loss of their respective patent protection, thus helping secure access to affordable, quality healthcare for patients worldwide.

Generic medicines offer the same quality and safety profiles as reference products. Throughout their development and production processes, generics are required to adhere to the same rigorous standards of quality, safety and efficacy as originator products, standards that are closely monitored and enforced by the relevant regulatory authorities both prior to and post product approval. Production plant is thus regularly inspected to ensure that it is and remains cGMP (current Good Manufacturing Practice) compliant ensuring continuous quality standards in the products.

Specialty Pharmaceutical Products

rontis-bullet New drug combinations
rontis-bullet Permeation/absorption enhancement
rontis-bullet Solubility enhancement
rontis-bullet Modified and sustained release tablets, capsules, pellets


Specialty pharmaceutical products that are safe and effective for use by the general public without a prescription are defined as over-the-counter (OTC) drugs. These drugs are often located on shelves in pharmacies with easy access by patients, but may also be located in non-pharmacy outlets, such as grocery stores, convenience marts and large discount retailers.


rontis-bulletEtoricoxib f.c tablets

rontis-bulletFebuxostat f.c tablets

Aprepitanrontis-bullett hard caps

rontis-bulletSilodosin hard caps

rontis-bulletRivaroxaban f.c tabs


Dronedarone f.c tablets


– For detailed information on the existing products offered through licensing activities, please contact our Licensing Department



For detailed information on the pipeline products offered through licensing activities, please contact our Licensing Department